CIK: 0001538653 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 14, 2024
Total Value ($000): $1,734,418 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CACC | CREDIT ACCEP CORP MICH | 1,560,014 | $831,066 | 47.9% | $107.75 | +317.3% | COM | 225310101 |
| CMPR | CIMPRESS PLC | 3,906,492 | $312,715 | 18.0% | $129.96 | -46.4% | SHS EURO | G2143T103 |
| WRLD | WORLD ACCEP CORP DEL | 2,037,495 | $265,954 | 15.3% | $81.92 | +43.0% | COM | 981419104 |
| W | WAYFAIR INC | 3,823,239 | $235,894 | 13.6% | $53.95 | -3.1% | CL A | 94419L101 |
| YELP | YELP INC | 918,446 | $43,479 | 2.5% | $30.67 | +43.9% | CL A | 985817105 |
| GIC | GLOBAL INDUSTRIAL COMPANY | 1,071,222 | $41,606 | 2.4% | $32.63 | +1.8% | COM | 37892E102 |
| LCTX | LINEAGE CELL THERAPEUTICS IN | 1,851,851 | $2,019 | 0.1% | $1.03 | +6.3% | COM | 53566P109 |
| HUMA | HUMACYTE INC | 568,246 | $1,614 | 0.1% | $6.34 | -59.5% | COM | 44486Q103 |
| — | AGEX THEREPEUTICS INC | 185,185 | $71 | 0.0% | $2.99 | — | COM | 00848H108 |